Intermittent Fasting and Inflammation: What the Research Actually Shows

Intermittent fasting, the practice of cycling between periods of eating and fasting rather than continuously restricting calories, has attracted substantial scientific interest over the past decade. While much of the popular discussion focuses on weight loss, the research on fasting and inflammation is independently compelling. Multiple clinical trials across diverse populations have found that various intermittent fasting protocols reduce CRP, IL-6, and TNF-alpha, often independently of significant changes in body weight.

Understanding why fasting reduces inflammation requires understanding what happens at the cellular and metabolic level during the fasted state, including processes like autophagy, ketone production, and the gut microbiome changes that fasting induces. These mechanisms explain both the anti-inflammatory effects observed and the differences between various fasting approaches.

What Happens During the Fasted State

In the first 12 to 18 hours of fasting, glycogen stores in the liver are depleted and insulin levels fall significantly. Low insulin is a primary anti-inflammatory signal: insulin promotes the uptake of glucose and fatty acids into cells, but also activates NF-kB, the master inflammatory transcription factor, in adipose tissue and immune cells. The insulin reduction during fasting removes this NF-kB stimulation, reducing downstream cytokine production across multiple tissue types.

Beyond 16 to 18 hours, the body begins producing significant quantities of beta-hydroxybutyrate (BHB), the primary ketone body derived from fatty acid oxidation. BHB has direct anti-inflammatory effects that operate independently of its role as an energy substrate. BHB inhibits the NLRP3 inflammasome, a key inflammatory signaling complex involved in the production of IL-1 beta and IL-18. It also acts as an HDAC inhibitor, influencing gene expression patterns toward reduced inflammatory cytokine production. A landmark study in Nature Medicine demonstrated that physiological BHB concentrations directly suppressed NLRP3-mediated inflammation in macrophages.

Autophagy: Cellular Cleanup as an Anti-Inflammatory Mechanism

One of the most important anti-inflammatory mechanisms triggered by fasting is autophagy, the cellular process by which damaged proteins, dysfunctional organelles, and cellular debris are engulfed and recycled. Autophagy is activated by nutrient deprivation, primarily through the deactivation of mTOR (mechanistic target of rapamycin), a nutrient-sensing kinase that suppresses autophagy when nutrients are abundant. Fasting activates autophagy robustly after approximately 16 to 24 hours in humans.

Autophagy reduces inflammation by clearing senescent cells and their pro-inflammatory secretions, removing damaged mitochondria that would otherwise release DAMPs and activate inflammasomes, and recycling misfolded proteins before they trigger immune responses. Research has found that individuals with impaired autophagy have chronically elevated inflammatory markers and faster biological aging. Restoring autophagy through fasting may therefore address a root cause of inflammaging rather than merely suppressing downstream symptoms.

Clinical Evidence: What the Trials Show

Several randomized controlled trials have examined the effects of intermittent fasting protocols on inflammatory markers. A 2019 meta-analysis of 18 trials found that various fasting protocols reduced CRP by an average of 0.9 mg/L, a clinically meaningful reduction in individuals with baseline elevations. The effects were observed with time-restricted eating (eating within a 6 to 10 hour window daily), alternate-day fasting, and the 5:2 protocol (five normal days plus two days of very low caloric intake per week).

A particularly well-designed 2022 trial in the New England Journal of Medicine compared time-restricted eating to standard caloric restriction with identical caloric deficits. Both groups lost similar amounts of weight, but the time-restricted eating group showed significantly greater reductions in IL-6 and TNF-alpha, suggesting that the timing and fasting period itself, beyond caloric restriction alone, contributes to the anti-inflammatory effect. The gut microbiome changes induced by fasting, including increased production of butyrate by gut bacteria during the fasting window, likely contribute to this differential effect.

Who Benefits Most, and Practical Considerations

The anti-inflammatory response to intermittent fasting appears strongest in individuals with elevated baseline inflammatory markers, those with metabolic syndrome, obesity, or existing low-grade chronic inflammation. For people with already-low baseline CRP and a high-quality diet, the incremental benefit is more modest. This pattern makes intuitive sense: if inflammation is already well-managed, there is less room for further reduction through any intervention.

From a practical standpoint, the 16:8 time-restricted eating protocol (fasting 16 hours, eating within an 8-hour window) is the most widely studied and generally well-tolerated approach. Most people achieve this by simply extending the overnight fast, skipping breakfast or eating an early first meal around noon. Key cautions: people with a history of eating disorders, those who are pregnant or breastfeeding, people with type 1 diabetes, and those on medications requiring food should consult a healthcare provider before beginning any fasting protocol.